Lori J. Pierce | |
|---|---|
| Born | Washington, D.C., USA |
| Academic background | |
| Education | BS, biomedical engineering, 1979, University of Pennsylvania MD, 1985, Duke University School of Medicine |
| Academic work | |
| Institutions | University of Michigan Perelman School of Medicine at the University of Pennsylvania National Cancer Institute |
Lori Jo Pierce is an American radiation oncologist and 57th President of the American Society of Clinical Oncology.[1] She is a Full Professor and Vice Provost for Academic and Faculty Affairs at the University of Michigan. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer, with emphasis on intensity modulated radiotherapy in node positive breast cancer, the use of radiosensitizing agents, and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.
In 2019, Pierce was elected a member of the National Academy of Medicine in recognition of her “research in developing radiation treatments for breast cancer that leverage advances in medical physics and laboratory science and for national efforts to draw women and people of color into medicine."